Prostate cancer is the second most diagnosed cancer and the fifth leading cause of cancer death among men worldwide. In the 1980s, the development and implementation of Prostate-Specific Antigen (PSA) testing for diagnosing prostate cancer led to a surge in the number of prostate cancer diagnoses. We explore the trends in recommendations and new innovations in adjunctive testing for prostate cancer screening.
Urologic oncology. 2024 Aug 09 [Epub ahead of print]
Daisy Obiora, Oluwaseun Orikogbo, Benjamin J Davies, Bruce L Jacobs
Division of Health Services Research, Department of Urology, University of Pittsburgh Medical Center., Division of Health Services Research, Department of Urology, University of Pittsburgh Medical Center. Electronic address: .